Real-world effectiveness and safety of tralokinumab therapy in moderate-to-severe atopic dermatitis: insights from the TREATgermany registry
Real-world evidence from the TREATgermany registry demonstrated that tralokinumab has robust effectiveness and good tolerability and may provide improvements also in difficult-to-treat body areas.
Authors
- Melina Fonfara (ORCID: https://orcid.org/0009-0000-9729-0494)
- Inken Harder (ORCID: https://orcid.org/0000-0002-3079-0440)
- Jan Hartmann (ORCID: https://orcid.org/0000-0003-1842-8219)
- Barbara Kind (ORCID: https://orcid.org/0009-0002-5254-6411)
- Thomas Werfel
- Dora Stölzl
- Jochen Schmitt
- Luise Heinrich
- Stephan Weidinger
Institutions
- Medizinische Hochschule Hannover (DE)
- ENT and Allergy (US)
- University Hospital Carl Gustav Carus (DE)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1093/ced/llaf516
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00